Intravenous immune globulin use in children

January 1992
CMAJ: Canadian Medical Association Journal;1/15/1992, Vol. 146 Issue 2, p121
Academic Journal
No abstract available.


Related Articles

  • Intravenous Immune Globulin in Autoimmune and Inflammatory Diseases. Gelfand, Erwin W. // New England Journal of Medicine;11/22/2012, Vol. 367 Issue 21, p2015 

    The article discusses the use of intravenous immune globulin in the treatment of autoimmune and inflammatory diseases. It explains the significance of regular immune globulin replacement in patients with antibody deficiencies. The clinical indications for using intravenous immune globulin in...

  • The Influence of Epstein-Barr Virus Seropositivity on the Efficacy of Intravenous Immune Globulin in Children with Immune Thrombocytopenic Purpura. Sturgill, Marc G.; Drachtman, Richard A.; Ettinger, Alice G.; Rubin, Joan; Ettinger, Lawrence J. // Clinical Pediatrics;Mar99, Vol. 38 Issue 3, p171 

    Evaluates the impact of acute Epstein-Barr virus (EBV) infections on the efficacy of intravenous immune globulin (IVIG) in children and adolescents with immune thrombocytopenic purpura (ITP). Materials and methods used in the study; Results; Discussion.

  • Immunomodulation of Autoimmune and Inflammatory Diseases with Intravenous Immune Globulin. Kazatchkine, Michel D.; Kaveri, Srini V. // New England Journal of Medicine;9/6/2001, Vol. 345 Issue 10, p747 

    The article discusses the use of intravenous immune globulin in immunomodulation of autoimmune and inflammatory diseases. According to the authors, intravenous immune globulin is a safe preparation with no long-term side effects. They recall that intravenous immune globulin was first...

  • IVIG: myocardial infarction, stroke and thrombosis.  // WHO Drug Information;2008, Vol. 22 Issue 1, p14 

    An excerpt from the Canadian Adverse Reaction Newsletter discussing the adverse effects of using intravenous immune globulin (IVIG) is presented.

  • High dose intravenous immune globulin in the treatment of hereditary recurrent brachial plexus neuropathy. G. Ardolino; S. Barbieri; A. Priori // Journal of Neurology, Neurosurgery & Psychiatry;Apr2003, Vol. 74 Issue 4, p550 

    Presents a letter to the editor on the use of high dose intravenous immune globulin in the treatment of hereditary recurrent brachial plexus neuropathy.

  • vaccinia immune globulin.  // Taber's Cyclopedic Medical Dictionary;2005, p2287 

    A definition of the term "vaccinia immune globulin" is presented. It refers to an immune globulin containing vaccinia-specific antibodies. It is used for dermal complications of vaccination for smallpox. An intravenous formulation is now being produced and tested.

  • Immune globulin.  // Reactions Weekly;12/10/2011, Issue 1381, p15 

    The article describes the clinical cases of four children who developed aseptic meningitis after receiving intravenous (IV) immune globulin for Kawasaki disease.

  • New uses for IGIV.  // FDA Consumer;Mar1994, Vol. 28 Issue 2, p7 

    Reports that Immune Globulin Intravenous (Human) (IGIV), which was first licensed by the Food and Drug Administration in 1981 to treat immune deficiency syndromes, was licensed December 27, 1993 for two new indications. Treatment of graft versus host disease in particular patients; Use to...

  • Safety of Immune Globulins in Relation to HTLV-III.  // Clinical Pediatrics;Feb1987, Vol. 26 Issue 2, p97 

    This article presents information on immune globulins. Laboratory tests by FDA scientists, as well as epidemiologic data evaluated by the Centers for Disease Control, show that therapeutic immune globulin preparations carry no discernible risk of transmitting HTLV-III infection and that their...

  • IVIG.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1242 

    An encyclopedia entry for the acronym "IVIG," which refers to intravenous immune globulin, is presented.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics